These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 37871164)
1. A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast Cancer. Pan WK; Ren SY; Zhu LX; Lin BC Am J Clin Oncol; 2024 Feb; 47(2):71-80. PubMed ID: 37871164 [TBL] [Abstract][Full Text] [Related]
2. Nomograms predict survival in elderly women with triple-negative breast cancer: A SEER population-based study. Feng R; Huang W; Liu B; Li D; Zhao J; Yu Y; Cao X; Wang X Technol Health Care; 2024; 32(4):2445-2461. PubMed ID: 38306071 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer. Chen MS; Liu PC; Yi JZ; Xu L; He T; Wu H; Yang JQ; Lv Q Sci Rep; 2022 Aug; 12(1):14659. PubMed ID: 36038627 [TBL] [Abstract][Full Text] [Related]
4. Construction of web Zhan G; Cao P; Peng H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884 [TBL] [Abstract][Full Text] [Related]
5. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study. Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027 [TBL] [Abstract][Full Text] [Related]
6. A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple-negative breast cancer. Lin M; Jin Y; Jin J; Wang B; Hu X; Zhang J Cancer Med; 2020 Nov; 9(22):8540-8551. PubMed ID: 32945619 [TBL] [Abstract][Full Text] [Related]
7. Triple-negative breast cancer survival prediction: population-based research using the SEER database and an external validation cohort. Qiu Y; Chen Y; Shen H; Yan S; Li J; Wu W Front Oncol; 2024; 14():1388869. PubMed ID: 38919536 [TBL] [Abstract][Full Text] [Related]
8. Prognosis of Patients With Triple-negative Breast Cancer: A Population-based Study From SEER Database. Zhou HL; Chen DD Clin Breast Cancer; 2023 Apr; 23(3):e85-e94. PubMed ID: 36669957 [TBL] [Abstract][Full Text] [Related]
9. Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study. Xie Y; Lei C; Ma Y; Li Y; Yang M; Zhang Y; Law KN; Wang N; Qu S BMC Womens Health; 2024 Jan; 24(1):16. PubMed ID: 38172874 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of a risk stratification nomogram for predicting prognosis in bone metastatic breast cancer: A population-based study. Hou N; Yi J; Wang Z; Yang L; Wu Y; Huang M; Hou G; Ling R Medicine (Baltimore); 2021 Feb; 100(6):e24751. PubMed ID: 33578627 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer. Wang J; Zhao H; Ye L; Li J; Zhang H; Zhang C; Rao Q; Cai Y; Xu Y; Deng Y Comput Math Methods Med; 2022; 2022():1750834. PubMed ID: 35991145 [TBL] [Abstract][Full Text] [Related]
12. Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysis. Xu Y; Zhang W; He J; Wang Y; Chen R; Shi W; Wan X; Shi X; Huang X; Wang J; Zha X Breast; 2022 Dec; 66():8-14. PubMed ID: 36084385 [TBL] [Abstract][Full Text] [Related]
13. A New Online Dynamic Nomogram: Construction and Validation of a Predictive Model for Distant Metastasis Risk and Prognosis in Patients with Gastrointestinal Stromal Tumors. Wu H; Ding P; Wu J; Sun C; Guo H; Chen S; Lowe S; Yang P; Tian Y; Liu Y; Zhao Q J Gastrointest Surg; 2023 Jul; 27(7):1429-1444. PubMed ID: 37231240 [TBL] [Abstract][Full Text] [Related]
14. A Nomogram and Risk Classification System Predicting the Prognosis of Patients with De Novo Metastatic Breast Cancer Undergoing Immediate Breast Reconstruction: A Surveillance, Epidemiology, and End Results Population-Based Study. Zhao J; Bian S; Di X; Xiao C Curr Oncol; 2023 Dec; 31(1):115-131. PubMed ID: 38248093 [TBL] [Abstract][Full Text] [Related]
15. Development and Validation of Prognostic Nomograms for Lung Squamous Cell Carcinoma With Brain Metastasis in Patients Aged 45 Years or Older: A Population-Based Study. Yang F; Gao L; Wang Q; Gao W Cancer Control; 2023; 30():10732748231202953. PubMed ID: 37776257 [TBL] [Abstract][Full Text] [Related]
16. The incidence, risk factors and predictive nomograms for early death of lung cancer with synchronous brain metastasis: a retrospective study in the SEER database. Shen H; Deng G; Chen Q; Qian J BMC Cancer; 2021 Jul; 21(1):825. PubMed ID: 34271858 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a nomogram for predicting the early death of anaplastic thyroid cancer: a SEER population-based study. Cui H; Wang R; Zhao X; Wang S; Shi X; Sang J J Cancer Res Clin Oncol; 2023 Nov; 149(17):16001-16013. PubMed ID: 37689588 [TBL] [Abstract][Full Text] [Related]
18. Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study. Zhang W; Ji L; Zhong X; Zhu S; Zhang Y; Ge M; Kang Y; Bi Q Front Public Health; 2022; 10():884349. PubMed ID: 35712294 [TBL] [Abstract][Full Text] [Related]
19. Risk factors, survival analysis, and nomograms for distant metastasis in patients with primary pulmonary large cell neuroendocrine carcinoma: A population-based study. Song Z; Zou L Front Endocrinol (Lausanne); 2022; 13():973091. PubMed ID: 36329892 [TBL] [Abstract][Full Text] [Related]
20. Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients with Primary Anaplastic Oligodendroglioma. Zhou S; Wu S; Li Z; Wang X World Neurosurg; 2024 Jul; 187():e472-e484. PubMed ID: 38677647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]